Short answer · Medically reviewed summary · Last updated: 2026-05-08
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a rare genetic disorder caused by mutations in the IGHMBP2 gene, which disrupts the production of a protein essential for motor neuron health. This condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene to develop the disease. What causes Spinal muscular atrophy with respiratory distress type 1? The primary cause of Spinal muscular atrophy with respiratory distress type 1 is a mutation in the IGHMBP2 gene located on chromosome 11.
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a rare genetic disorder caused by mutations in the IGHMBP2 gene, which disrupts the production of a protein essential for motor neuron health. This condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene to develop the disease.
The primary cause of Spinal muscular atrophy with respiratory distress type 1 is a mutation in the IGHMBP2 gene located on chromosome 11. This gene provides instructions for creating an enzyme involved in DNA replication and RNA processing. When this gene is faulty, it leads to the degeneration of alpha motor neurons in the spinal cord, which are responsible for controlling voluntary muscles, including the diaphragm, leading to the hallmark respiratory distress seen in Spinal muscular atrophy with respiratory distress type 1.
Yes, Spinal muscular atrophy with respiratory distress type 1 is strictly a genetic condition. It follows an autosomal recessive inheritance pattern, which means:
Unlike some complex diseases, Spinal muscular atrophy with respiratory distress type 1 is not caused by lifestyle, diet, or autoimmune responses. Research is currently focused on why mutations in the same gene can lead to a spectrum of clinical severity, ranging from early-onset SMARD1 to milder forms of distal hereditary motor neuropathy. Scientists are investigating how IGHMBP2 deficiency triggers cellular stress and whether therapeutic gene replacement or mRNA stabilization could restore motor neuron function.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.